Psyence Biomedical Ltd Stock Analysis
PBM Stock | USD 3.46 0.05 1.42% |
Psyence Biomedical Ltd is overvalued with Real Value of 3.04 and Hype Value of 4.27. The main objective of Psyence Biomedical stock analysis is to determine its intrinsic value, which is an estimate of what Psyence Biomedical Ltd is worth, separate from its market price. There are two main types of Psyence Biomedical's stock analysis: fundamental analysis and technical analysis.
The Psyence Biomedical stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Psyence Biomedical is usually not traded on Juneteenth Holiday, Independence Day, Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day. Psyence Stock trading window is adjusted to America/New York timezone.
Psyence |
Psyence Stock Analysis Notes
About 58.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 7.82. Psyence Biomedical had not issued any dividends in recent years. The entity had 1:5 split on the July 9, 2013. Pacific Booker Minerals Inc. engages in the exploration of mineral properties in Canada. To find out more about Psyence Biomedical Ltd contact Neil MD at 416-346-7764 or learn more at https://www.psyencebiomed.com.Psyence Biomedical Investment Alerts
Psyence Biomedical generated a negative expected return over the last 90 days | |
Psyence Biomedical has high historical volatility and very poor performance | |
Psyence Biomedical has a very high chance of going through financial distress in the upcoming years | |
Reported Net Loss for the year was (51.16 M) with profit before taxes, overhead, and interest of 0. | |
Psyence Biomedical Ltd has about 281.63 K in cash with (2.95 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.02. | |
Psyence Biomedical has a frail financial position based on the latest SEC disclosures | |
Roughly 58.0% of the company outstanding shares are owned by corporate insiders | |
Latest headline from businesswire.com: VIVIO Extends Open Market Specialty Drug Platform to Solve Our PBM Crisis |
Psyence Market Capitalization
The company currently falls under 'Nano-Cap' category with a total capitalization of 2.6 M.Psyence Profitablity
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | (45.19) | (42.93) | |
Return On Capital Employed | 0.25 | 0.26 | |
Return On Assets | (45.19) | (42.93) | |
Return On Equity | 4.66 | 4.90 |
Management Efficiency
Psyence Biomedical has Return on Asset of (1.2635) % which means that on every $100 spent on assets, it lost $1.2635. This is way below average. Psyence Biomedical's management efficiency ratios could be used to measure how well Psyence Biomedical manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Psyence Biomedical's Return On Capital Employed is very stable compared to the past year. As of the 1st of December 2024, Return On Equity is likely to grow to 4.90, though Return On Tangible Assets are likely to grow to (42.93). At this time, Psyence Biomedical's Total Current Assets are very stable compared to the past year. Non Currrent Assets Other is expected to grow at the current pace this year, while Total Assets are likely to drop about 1.1 M.Last Reported | Projected for Next Year | ||
Book Value Per Share | (1.68) | (1.60) | |
Tangible Book Value Per Share | (1.68) | (1.60) | |
Enterprise Value Over EBITDA | (206.04) | (216.34) | |
Price Book Value Ratio | (50.78) | (48.24) | |
Enterprise Value Multiple | (206.04) | (216.34) | |
Price Fair Value | (50.78) | (48.24) | |
Enterprise Value | 510.2 M | 453.5 M |
Psyence Biomedical's management has consistently demonstrated strong leadership, driving both financial growth and operational excellence. By analyzing current market trends and future growth opportunities, we assess the stock's true value and potential for investors.
Beta (0.36) | Return On Assets (1.26) |
Technical Drivers
As of the 1st of December, Psyence Biomedical holds the Variance of 85.61, coefficient of variation of (319.23), and Risk Adjusted Performance of (0.23). Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Psyence Biomedical, as well as the relationship between them. Please check Psyence Biomedical risk adjusted performance, variance, as well as the relationship between the Variance and potential upside to decide if Psyence Biomedical is priced some-what accurately, providing market reflects its current price of 3.46 per share. Given that Psyence Biomedical has information ratio of (0.33), we recommend you to check out Psyence Biomedical's recent market performance to make sure the company can sustain itself at a future point.Psyence Biomedical Price Movement Analysis
The output start index for this execution was nine with a total number of output elements of fifty-two. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Psyence Biomedical middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Psyence Biomedical. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Psyence Biomedical Predictive Daily Indicators
Psyence Biomedical intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Psyence Biomedical stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Psyence Biomedical Corporate Filings
6K | 22nd of November 2024 A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges. | ViewVerify |
13A | 13th of November 2024 An amended filing to the original Schedule 13G | ViewVerify |
13A | 12th of November 2024 The form used by investors holding more than 5% of a company's stock, to report their beneficial ownership pursuant to Rule 13d-1 or Rule 13d-2 under the Securities Exchange Act of 1934 | ViewVerify |
6K | 1st of November 2024 A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges. | ViewVerify |
30th of October 2024 Other Reports | ViewVerify | |
6K | 23rd of October 2024 A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges. | ViewVerify |
10th of October 2024 Other Reports | ViewVerify | |
6K | 8th of October 2024 A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges. | ViewVerify |
Psyence Biomedical Forecast Models
Psyence Biomedical's time-series forecasting models are one of many Psyence Biomedical's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Psyence Biomedical's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Psyence Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Psyence Biomedical prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Psyence shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Psyence Biomedical. By using and applying Psyence Stock analysis, traders can create a robust methodology for identifying Psyence entry and exit points for their positions.
Last Reported | Projected for Next Year |
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Psyence Biomedical to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Portfolio Dashboard Now
Portfolio DashboardPortfolio dashboard that provides centralized access to all your investments |
All Next | Launch Module |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Psyence Biomedical Ltd. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Psyence Biomedical. If investors know Psyence will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Psyence Biomedical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (7.82) | Return On Assets (1.26) |
The market value of Psyence Biomedical is measured differently than its book value, which is the value of Psyence that is recorded on the company's balance sheet. Investors also form their own opinion of Psyence Biomedical's value that differs from its market value or its book value, called intrinsic value, which is Psyence Biomedical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Psyence Biomedical's market value can be influenced by many factors that don't directly affect Psyence Biomedical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Psyence Biomedical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Psyence Biomedical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Psyence Biomedical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.